)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Monsenso
Monsenso (MONSO) investor relations material
Monsenso H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary28 Aug, 2026
Executive summary
Revenue for H1 2026 was DKK 3,329k, down from DKK 5,166k in H1 2025, mainly due to customer implementation delays; revenue is expected to recover in H2 2026 to meet full-year targets.
Commercial revenue grew by 56% year-over-year, driven by contracts with Danish, Austrian, and UK health providers, including a significant new ADHD services contract in the UK.
Innovation and research activities declined as projects moved to operational stages, but new patient recruitment and promising study results are expected in H2 2026 and 2027.
Financial highlights
EBITDA improved to DKK -1,277k from DKK -1,755k year-over-year; EBIT was DKK -3,356k versus DKK -4,066k.
Gross margin increased to 47% from 37% year-over-year.
Cash flow from operations was DKK -1,682k, offset by a capital increase of DKK 3,118k.
Net loss for the period was DKK -3,388k, compared to DKK -3,839k in H1 2025.
Market capitalization rose to DKK 34.1m from DKK 22.0m year-over-year.
Outlook and guidance
Full-year 2026 revenue expected at DKK 11m, representing 24% growth.
H2 2026 EBITDA and operating cash flow are expected to turn positive.
Year-end 2026 guidance includes slightly positive EBITDA, positive cash position, and EBIT of DKK -4m due to software depreciation.
Management expects sufficient liquidity for ongoing operations.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Monsenso
- Revenue declined 20% amid project delays, with future growth hinging on new orders.MONSO
H2 2025 - Revenue fell 7% but operational cash flow improved; new projects set to drive H2 growth.MONSOH1 2025
- Revenue up 25% and cash position strengthened by DKK 9.3m capital raise in H1 2024.MONSOH1 2024
- Monsenso achieved strong revenue growth in 2024 but remains in investment mode with a net loss.MONSOH2 2024
Next Monsenso earnings date
H2 20265 Mar, 2027
Monsenso
Next Monsenso earnings date
H2 20265 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Monsenso A/S is a technology company specializing in the development of digital health solutions. The company provides a platform that helps improve mental health care by offering tools for the real-time monitoring and management of mental health conditions. Monsenso’s platform is designed for use by healthcare providers and patients, allowing the collection of data through mobile apps, sensors, and other digital means. This data is used to enhance clinical decision-making and treatment outcomes. The company operates primarily in the healthcare and wellness sectors, focusing on mental health and chronic condition management. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Copenhagen Stock Exchange.